Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant vs Desloratadine for EGFR-TKI Induced Pruritus
NCT02646020Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2015
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in pruritus, sponsored by Sun Yat-sen University. Started Dec 2015; status: completed.
02
Drugs
aprepitant
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT02646020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646020.